EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Long-Term Prognostic Analysis of Chemoradiation Therapy Versus Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results From a Prospective Randomized Control Study

Xia-Xi Qiao, Huan-Gang Jiang, Yuan Tang, Jin-Ming Shi, Li-Ming Jiang, Lin Yang, Qing Hou, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Hui Fang, Bo Chen und 8 weitere

International Journal of Radiation Oncology*Biology*Physics · 2025

DOI: 10.1016/j.ijrobp.2025.03.044 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Xia-Xi Qiao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sci…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Chemoradiotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzen Municipality, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To explore the population of patients who could benefit from adjuvant radiation therapy (RT) and investigated the value of postoperative chemoradiation therapy (CRT) in patients with gastric cancer after D2 resection. METHODS AND MATERIALS: This randomized clinical trial enrolled patients between October 1, 2011, and December 31, 2019. Patients with gastric cancer who underwent D2 gastrectomy were randomized (1:1) to receive postoperative CRT or adjuvant chemotherapy after surgery. The adjuvant chemotherapy group received 8 cycles of SOX (S-1 + oxaliplatin) chemotherapy. RT was given after 4 to 6 cycles of SOX chemotherapy. RT comprised 45 Gy in 25 fractions of 1.8 Gy over 5 weeks by intensity modulated RT concurrently with S-1 chemotherapy. The primary endpoint was 3-year disease-free survival (DFS). RESULTS: A total of 312 patients (median [IQR] age, 58 [50-64] years) were enrolled, including 157 patients randomized to the adjuvant chemotherapy group and 155 patients randomized to the adjuvant CRT group. The 3-year DFS was 66.7% for the control arm and 70.7% for the experimental arm (hazard ratio [HR], 0.82; 95% CI, 0.54-1.25; P = .35). We defined patients with pN stage ≥ N2 and extraperigastric lymph node metastasis as the high-risk group and the remaining patients as the low-risk group. The 3-year DFS rates for the high-risk group and the low-risk group were 59.3% and 76.8%, respectively (HR, 2.11; 95% CI, 1.39-3.22; P < .01). For high-risk patients, the 3-year DFS rates in the adjuvant chemotherapy and adjuvant CRT groups were 53.0% and 71.0%, respectively (HR, 0.53; 95% CI, 0.29-0.97; P < .05). More grade 3 and 4 acute toxic effects were observed in the adjuvant chemotherapy group than in the CRT group (41 patients [26.1%] vs 28 patients [18.5%]; P = .11), but the difference was not significant. CONCLUSIONS: Subgroup analysis of this randomized clinical trial revealed that high-risk patients can benefit from adjuvant CRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsChemoradiotherapyHumansMiddle AgedMaleFemaleGastrectomyChemotherapy, AdjuvantProspective StudiesOxaliplatinDisease-Free SurvivalPrognosisAntineoplastic Combined Chemotherapy ProtocolsTegafurOxonic AcidChemoradiotherapy, AdjuvantDrug CombinationsRadiotherapy, Intensity-Modulated

Substanzen

OxaliplatinTegafurS 1 (combination)Oxonic AcidDrug Combinations

Autor:innen und Institutionen

  • Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • State Key Laboratory of Molecular Oncology and Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical C…
  • State Key Laboratory of Molecular Oncology and Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Me…
  • Department of Radiotherapy, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
  • Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. El…

Förderung

  • National Natural Science Foundation of China
  • Sanming Project of Medicine in Shenzen Municipality
  • Chinese Academy of Medical Sciences

Zitieren

APA

Qiao, X. X., Jiang, H. G., Tang, Y., Shi, J. M., Jiang, L. M., Yang, L., Hou, Q., Wang, S. L., Song, Y. W., Liu, Y. P., Fang, H., Chen, B., Lu, N. N., Qi, S. N., Li, Y. X., Cao, J. Z., Zhou, F. X., Zhao, D. B., Li, N., & Jin, J. (2025). Long-Term Prognostic Analysis of Chemoradiation Therapy Versus Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results From a Prospective Randomized Control Study. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.03.044

Vancouver

Qiao XX, Jiang HG, Tang Y, Shi JM, Jiang LM, Yang L, et al. Long-Term Prognostic Analysis of Chemoradiation Therapy Versus Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results From a Prospective Randomized Control Study. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.03.044

BibTeX
@article{Qiao2025,
  author = {Qiao, Xia-Xi and Jiang, Huan-Gang and Tang, Yuan and Shi, Jin-Ming and Jiang, Li-Ming and Yang, Lin and Hou, Qing and Wang, Shu-Lian and Song, Yong-Wen and Liu, Yue-Ping and Fang, Hui and Chen, Bo and Lu, Ning-Ning and Qi, Shu-Nan and Li, Ye-Xiong and Cao, Jian-Zhong and Zhou, Fu-Xiang and Zhao, Dong-Bing and Li, Ning and Jin, Jing},
  title = {Long-Term Prognostic Analysis of Chemoradiation Therapy Versus Chemotherapy after D2 Resection for High-Risk Gastric Cancer: Results From a Prospective Randomized Control Study},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2025},
  doi = {10.1016/j.ijrobp.2025.03.044}
}
Kostenlos starten →